Correlation Between INGERSOLL and Tarsus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both INGERSOLL and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INGERSOLL and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between INGERSOLL RAND LUXEMBOURG FINANCE and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on INGERSOLL and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INGERSOLL with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of INGERSOLL and Tarsus Pharmaceuticals.

Diversification Opportunities for INGERSOLL and Tarsus Pharmaceuticals

-0.62

Correlation Coefficient

INGERSOLL  Tarsus Pharmaceuticals

Excellent diversification

The 3 months correlation between INGERSOLL and Tarsus is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding INGERSOLL RAND LUXEMBOURG FINA and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and INGERSOLL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INGERSOLL RAND LUXEMBOURG FINANCE are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of INGERSOLL i.e., INGERSOLL and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between INGERSOLL and Tarsus Pharmaceuticals

Assuming the 90 days trading horizon INGERSOLL is expected to generate 242.47 times less return on investment than Tarsus Pharmaceuticals. But when comparing it to its historical volatility, INGERSOLL RAND LUXEMBOURG FINANCE is 10.77 times less risky than Tarsus Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  2,109  in Tarsus Pharmaceuticals on October 6, 2024 and sell it today you would earn a total of  3,458  from holding Tarsus Pharmaceuticals or generate 163.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	97.18%
Values	Daily Returns

INGERSOLL RAND LUXEMBOURG FINA  vs.  Tarsus Pharmaceuticals

INGERSOLL RAND LUXEM

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days INGERSOLL RAND LUXEMBOURG FINANCE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, INGERSOLL is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Tarsus Pharmaceuticals

Risk-Adjusted Performance

26 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with INGERSOLL and Tarsus Pharmaceuticals

The main advantage of trading using opposite INGERSOLL and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INGERSOLL position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.

The idea behind INGERSOLL RAND LUXEMBOURG FINANCE and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..